Georgios Karanikas
Overview
Explore the profile of Georgios Karanikas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Einspieler H, Hennig B, Reiterits B, Klimpfinger H, Hacker M, Karanikas G
Thyroid
. 2025 Mar;
PMID: 40053389
This retrospective case-control study aimed to investigate the effects of thyroid-stimulating hormone (TSH) suppression on vascular wall inflammation, assessed by [F]-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). Vascular [F]FDG-uptake...
2.
Zhang Z, Yu J, Rainer E, Hargitai L, Jiang Z, Karanikas G, et al.
Eur Thyroid J
. 2024 Jun;
13(4).
PMID: 38900599
Objective: Correct diagnosis and prognostic evaluation of medullary thyroid cancer (MTC) are crucial to treat patients. The purpose of this study was to evaluate the diagnostic and prognostic value of...
3.
Kraus T, Shengelia-de Lange N, Einspieler H, Hacker M, Haug A, Kretschmer-Chott E, et al.
Endocr Connect
. 2024 Mar;
13(5).
PMID: 38513355
Background: The most important part of the follow-up of differentiated thyroid carcinoma (DTC) is the measurement of serum thyroglobulin (Tg). An increase of Tg levels indicates likely tumor recurrence. According...
4.
Einspieler H, Walter C, Hacker M, Karanikas G, Tamandl D
Sci Rep
. 2023 Dec;
13(1):22640.
PMID: 38114753
Iatrogenic subclinical hyperthyroidism is induced intentionally in patients with differentiated thyroid cancer to reduce the risk of tumor recurrence. This retrospective study aimed to investigate the effect of thyroid-stimulating hormone...
5.
Reed M, Godbersen G, Vraka C, Rausch I, Ponce de Leon M, Popper V, et al.
Front Physiol
. 2023 Apr;
14:1074052.
PMID: 37035658
Dynamic positron emission tomography (PET) and the application of kinetic models can provide important quantitative information based on its temporal information. This however requires arterial blood sampling, which can be...
6.
Reed M, Ponce de Leon M, Vraka C, Rausch I, Godbersen G, Popper V, et al.
Neuroimage
. 2023 Mar;
271:120030.
PMID: 36925087
The nervous and circulatory system interconnects the various organs of the human body, building hierarchically organized subsystems, enabling fine-tuned, metabolically expensive brain-body and inter-organ crosstalk to appropriately adapt to internal...
7.
Bamminger K, Raitanen J, Karanikas G, Rasul S, Nics L, Mitterhauser M, et al.
Nucl Med Biol
. 2022 Jul;
114-115:189-197.
PMID: 35820986
No abstract available.
8.
Zisser L, Kulterer O, Itariu B, Fueger B, Weber M, Mazal P, et al.
Anticancer Res
. 2021 May;
41(5):2477-2484.
PMID: 33952474
Background/aim: Positron emission tomography/computed tomography (PET/CT) plays an important role in cancer localization in ectopic Cushing's syndrome (ECS). However, the choice of the optimal tracer for investigation of this disease...
9.
Krajnc D, Papp L, Nakuz T, Magometschnigg H, Grahovac M, Spielvogel C, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33809057
: This study investigated the performance of ensemble learning holomic models for the detection of breast cancer, receptor status, proliferation rate, and molecular subtypes from [F]FDG-PET/CT images with and without...
10.
Bauer M, Barna S, Blaickner M, Prosenz K, Bamminger K, Pichler V, et al.
Mol Imaging Biol
. 2021 Jan;
23(2):180-185.
PMID: 33481175
Purpose: To assess in healthy volunteers the whole-body distribution and dosimetry of [C]metoclopramide, a new positron emission tomography (PET) tracer to measure P-glycoprotein activity at the blood-brain barrier. Procedures: Ten...